Most Read Articles
Elvira Manzano, 3 days ago
Monthly injections of the PCSK9* monoclonal antibody evolocumab effectively reduced plasma LDL-cholesterol (LDL-C), often referred to as the bad cholesterol, in teenagers with heterozygous familial hypercholesterolaemia (HeFH) already taking statins, with or without ezetimibe, the HAUSER-RCT has shown.
Jairia Dela Cruz, 3 days ago
For individuals with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
In patients with type 2 diabetes (T2D), postprandial hyperglycaemia and hypertriglyceridemia worsens survival outlook, finds a new study.

Knee osteoarthritis heightens mortality risk

01 Apr 2020

Knee osteoarthritis (OA), whether symptomatic or radiographic, contributes to an increased risk of all-cause mortality, with the risk increase from symptomatic knee OA partially attributed to its effect on disability and quality of life (QoL).

The study used data from the Osteoarthritis Initiative and included 1,387 participants with symptomatic knee OA (ie, both radiographic knee OA [Kellgren and Lawrence grade ≥2]) and knee pain), 856 with knee pain only, 1,117 with radiographic knee OA only, and 1,139 with neither radiographic knee OA nor knee pain.

Compared with those who had neither radiographic knee OA nor knee pain, participants with symptomatic knee OA were more likely to have higher body mass index and disability score, more comorbidities, depressive symptoms, widespread pain, knee injury history, and oral pain medications use. They also had lower physical (PCS) and mental component summary scores (MCS) of QoL.

Over a follow-up of 96 months, 282 participants died. In multivariable Cox‐proportional models, the risk of all-cause mortality was higher in participants with symptomatic knee OA (hazard ratio [HR], 2.2, 95 percent confidence interval [CI], 1.6–3.1), with knee pain only (HR, 0.9, 95 percent CI, 0.6–1.4) or with radiographic knee OA only (HR, 2.0, 95 percent CI, 1.4–2.9) relative to those with neither radiographic knee OA nor knee pain.

Symptomatic knee OA exerted an indirect effect on mortality via PCS of QoL (HR, 1.2, 95 percent CI, 1.0–1.4; percentage of mediation, 26.5 percent) and disability (HR, 1.1, 95 percent CI, 1.0–1.4; percentage of mediation, 22.4 percent). There was no apparent mediation effect seen via either MCS of QoL or the use of oral pain relief medications.

The present data highlight the importance of developing appropriate preventive and treatment strategies to reduce the risk of knee OA, as well as interventions focused on improving function and QoL to reduce all-cause mortality among patients with symptomatic knee OA, according to researchers.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Rheumatology digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elvira Manzano, 3 days ago
Monthly injections of the PCSK9* monoclonal antibody evolocumab effectively reduced plasma LDL-cholesterol (LDL-C), often referred to as the bad cholesterol, in teenagers with heterozygous familial hypercholesterolaemia (HeFH) already taking statins, with or without ezetimibe, the HAUSER-RCT has shown.
Jairia Dela Cruz, 3 days ago
For individuals with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
In patients with type 2 diabetes (T2D), postprandial hyperglycaemia and hypertriglyceridemia worsens survival outlook, finds a new study.